US2019192526A1PendingUtilityA1

Aryl-or heteroaryl-substituted benzene compounds

Assignee: EPIZYME INCPriority: Apr 13, 2011Filed: Mar 4, 2019Published: Jun 27, 2019

Est. expiryApr 13, 2031(~4.7 yrs left)· nominal 20-yr term from priority

Inventors:Kevin Wayne Kuntz Richard Chesworth Kenneth W. Duncan Masashi Seki Syuji Shirotori

A61P 43/00A61P 35/02A61P 35/00A61K 31/4433C07D 213/64C07D 491/107A61K 31/496A61K 31/4545A61K 31/551C07D 417/12A61K 31/4436A61K 31/443C07D 409/12A61K 31/553C07D 405/12C07D 213/81A61K 31/444C07D 401/12C07D 491/08A61K 31/5377C07D 498/08A61K 31/4439C07D 405/14C07D 413/12A61K 31/4709A61K 31/4412A61K 31/506C07D 401/14C07D 413/14C07D 309/08C07C 229/54

PatentIndex Score

Cited by

References

Claims

Abstract

The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Claims

exact text as granted — not AI-modified

What is claimed is: 
     
         1 . A compound, which is

Join the waitlist — get patent alerts

Track US2019192526A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.